Cas 1036751-66-2,7-(2-chloropyridin-4-yloxy)-N-(3-fluorophenyl)-6-(thiazol-2-yl)quinazolin-2-amine

1036751-66-2

Post Buying Request

Basic information

Product Name: 7-(2-chloropyridin-4-yloxy)-N-(3-fluorophenyl)-6-(thiazol-2-yl)quinazolin-2-amine
Synonyms: 7-(2-chloropyridin-4-yloxy)-N-(3-fluorophenyl)-6-(thiazol-2-yl)quinazolin-2-amine
CAS NO:1036751-66-2
Molecular Formula:
Molecular Weight: 449.896
EINECS: N/A
Product Categories: N/A
Mol File: 1036751-66-2.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 7-(2-chloropyridin-4-yloxy)-N-(3-fluorophenyl)-6-(thiazol-2-yl)quinazolin-2-amine(CAS DataBase Reference)
NIST Chemistry Reference: 7-(2-chloropyridin-4-yloxy)-N-(3-fluorophenyl)-6-(thiazol-2-yl)quinazolin-2-amine(1036751-66-2)
EPA Substance Registry System: 7-(2-chloropyridin-4-yloxy)-N-(3-fluorophenyl)-6-(thiazol-2-yl)quinazolin-2-amine(1036751-66-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1036751-66-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1036751-66-2 Suppliers

Recommended suppliersmore

1036751-66-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1036751-66-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,6,7,5 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1036751-66:
(9*1)+(8*0)+(7*3)+(6*6)+(5*7)+(4*5)+(3*1)+(2*6)+(1*6)=142
142 % 10 = 2
So 1036751-66-2 is a valid CAS Registry Number.

1036751-66-2Upstream product

1036751-66-2Downstream Products

1036751-66-2Relevant articles and documents

QUINAZOLINES FOR PDK1 INHIBITION

-

Page/Page column 132-133, (2010/09/05)

The invention provides novel compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1036751-66-2